Ohtuvayre (Ensifentrine)
- Medicine Name: Ohtuvayre
- API: Ensifentrine
- Dosage Form & Strength: Inhalation suspension: 3 mg/2.5 mL aqueous suspension in unit-dose ampules
- Manufactured By: Verona Pharma plc
Ohtuvayre (ensifentrine) is a dual phosphodiesterase 3 (PDE3) and phosphodiesterase 4 (PDE4) inhibitor designed for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adults. By targeting PDE3 and PDE4, Ohtuvayre helps improve lung function, reduce inflammation, and enhance breathing. This innovative therapy offers a new option for COPD management, providing significant relief to patients suffering from this chronic condition.
Recommended Dosage: The recommended dosage is 3 mg (one unit-dose ampule) administered twice daily, morning and evening. It is taken through oral inhalation using a standard jet nebulizer with a mouthpiece. Ensifentrine offers relief by helping open airways and improving lung function. For those with chronic obstructive pulmonary disease (COPD) or asthma, this treatment can enhance breathing.
- Ohtuvayre 3 mg/2.5 mL inhalation suspension is not intended for treating acute bronchospasm episodes. If an acute attack occurs, immediate treatment with a rescue inhaler should be sought. Consult your healthcare provider for proper management. Always carry emergency medications.
- Treatment with this medicine may cause paradoxical bronchospasm, which can be life-threatening. If symptoms worsen after using the medication, discontinue use immediately and seek medical attention. This rare reaction requires urgent medical intervention to prevent severe complications.
- Patients using Ensifentrine 3 mg/2.5 mL should be monitored for psychiatric events, including anxiety, depression, and suicidal thoughts. If any abnormal mental health changes occur, seek medical advice promptly. This precaution is critical, especially in patients with a history of mental illness.
- The use of Ensifentrine during pregnancy should only occur if needed, as its safety in pregnant women has not been fully established. Consult your healthcare provider to assess the potential risks and benefits before using this medication during pregnancy.
- This therapeutic drug may pass into breast milk. Mothers who are breastfeeding should consult their healthcare provider to evaluate the risks and benefits before using ensifentrine. Caution is advised, as the effects on the nursing infant are unknown.
- A valid prescription from a qualified doctor.
- Patients diagnostic reports
- Patient ID proof (issued by the government of India)
- On availability of Ohtuvayre in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
- On availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait, Iraq, Saudi Arabia, and the UAE).
- Medicine Price.
- Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
- Ensuring 100% transparency.
Indian Pharma Network can source the OHTUVAYRE (Cancer Treatment Medicines) from across the globe and can supply. Indian Pharma offers its customers worldwide access to the best available treatment.
Indian Pharma Network (IPN) can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.
What is the Generic Name for the trade name drug Adakveo®?
Crizanlizumab-tmca is a Generic Name for the trade name drug Adakveo®.
What is the Manufacturer’s Name of Adakveo®?
Adakveo® is manufactured by Novartis Pharmaceuticals Corporation.
Is Adakveo® approved by the FDA?
Yes, Adakveo® is approved by the FDA. Date of first/initial approval: November 15, 2019.
Where can I get Adakveo® at the best price in India?
To get the best Adakveo price in India, kindly get in touch with Indian Pharma Network (a WHO GDP and ISO 9001:2008 certified company). For Adakveo®, a valid medical prescription is required from a treating physician.
What is the dosage and form of Adakveo® supplied?
Adakveo® is supplied in the form of an Injection: 100 mg/10 mL solution in a single-dose vial for IV or intravenous administration.
What are the most common side effects of Adakveo®?
The most common side effects of Adakveo® are nausea, back pain, arthralgia, and pyrexia.
How much does Adakveo® cost in India?
The cost of Adakveo in India can vary. In order to procure this medication authentically, you can Call or WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.
What are the storage conditions of Adakveo®?
Store and transport refrigerated at 2-8°C (36-46°F) in the original carton to protect from light. Neither shake nor freeze it.
Is it safe to buy Adakveo® online in India?
Yes, one can buy Adakveo in India at the best price from the Indian Pharma Network (IPN) if Adakveo is not registered or is unavailable in the respective country. We can facilitate the Import of Adakveo 100 mg injection through legal channels.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.